ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $48,479 | +880.8% | 13,392 | +769.6% | 0.00% | – |
| Q1 2024 | $4,943 | -29.0% | 1,540 | +8.5% | 0.00% | – |
| Q4 2023 | $6,958 | -16.3% | 1,420 | -6.9% | 0.00% | – |
| Q3 2023 | $8,317 | -18.8% | 1,526 | 0.0% | 0.00% | – |
| Q2 2023 | $10,239 | +19590.4% | 1,526 | -74.2% | 0.00% | – |
| Q1 2023 | $52 | +15.6% | 5,926 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 5,926 | 0.0% | 0.00% | – |
| Q3 2022 | $46,000 | -4.2% | 5,926 | -0.9% | 0.00% | – |
| Q2 2022 | $48,000 | +2300.0% | 5,978 | +3683.5% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 158 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -76.9% | 158 | -57.9% | 0.00% | – |
| Q3 2021 | $13,000 | -90.7% | 375 | -89.0% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | +1.4% | 3,416 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $138,000 | -31.7% | 3,416 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $202,000 | – | 3,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
| Triatomic Management LP | 98,555 | $316,362 | 0.59% |
| Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
| Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
| Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
| Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
| Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
| DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |